Rise and shine, everyone, another busy day is on the way. Our first clue is that the short person has left summer behind and is now stationed in front of a laptop for remote learning. And since the official mascot has successfully completed his morning calisthenics, we are free to get cracking. Toward that end, we are firing up the coffee kettle and examining our to-do list. Meanwhile, here are a few items of interest. We hope your journey today is productive and, as always, do keep in touch. We appreciate the feedback and juicy tips. …
A large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca (AZN) and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom, STAT reports. AstraZeneca initiated the study hold. The nature of the adverse reaction and when it happened were not immediately known, but the participant is expected to recover.
An unsubstantiated claim two weeks ago by President Trump — that the “deep state” was slowing approval of a Covid-19 vaccine — has set off an effort by government officials and private industry to ensure the White House doesn’t interfere with a methodical, careful scientific process, Bloomberg News reports. Food and Drug Administration officials are insulating agency vaccine reviewers from outside political pressure by sticking to June guidelines that set the standard for what it will take for a vaccine to pass through the agency.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect